30 High-Yield Topics in Medicine for NEET-PG 2026 — The Complete Subject Strategy

Medicine carries roughly 21 questions in NEET-PG 2026 — that’s 84 marks out of 800, the single biggest weight of any subject. Master Medicine well and you’ve secured more than 10% of the paper before opening another book.

The catch: Medicine is too vast to study cover-to-cover in your final months. The students who break top ranks don’t read Harrison’s end-to-end — they identify the 30 to 40 topics that account for most of NEET-PG’s Medicine questions and drill those to mastery. This guide gives you that list, organised by specialty, with study sequence and trap callouts.

Why Medicine Dominates NEET-PG 2026

• Largest single subject — 21 questions (84 marks). Surgery is close at 23 questions but those include Orthopedics overlap.
• 30% PYQ repeat rate at the concept level. The same diabetic ketoacidosis or rheumatic-fever logic appears almost every year, often in a fresh clinical wrapper.
• Cross-subject leverage. Medicine concepts (ACS, sepsis, CKD, diabetes) reappear inside Surgery, Pharmacology, Pathology, and even OBG questions. Strong Medicine raises your score across the paper.
• Clinical-reasoning shift. Recent NEET-PG papers favour scenario-based questions (“a 55-year-old man with chest pain…”) over pure recall. Medicine is the subject where this trend is sharpest.

Specialty Weightage Inside Medicine (Approximate)

The 30 High-Yield Medicine Topics for NEET-PG 2026

★ Cardiology (Topics 1–5)

1. ECG interpretation. Axis deviation, P-R interval, Q-T interval, ST changes, classic patterns (RBBB, LBBB, WPW, hyperkalaemia tall-T, hypocalcaemia long-QT). Image-based ECG questions appear in almost every NEET-PG paper.

2. Acute coronary syndrome (STEMI / NSTEMI / unstable angina). Time-window for thrombolysis vs primary PCI, classic enzyme rise pattern (troponin > CK-MB > LDH), GRACE / TIMI risk scoring. Heavily tested with bedside scenarios.

3. Heart failure (HFrEF vs HFpEF). Guideline-directed medical therapy (GDMT): ACE-I / ARB / ARNI + beta-blocker + MRA + SGLT2 inhibitor (dapagliflozin, empagliflozin — added to first line in recent guidelines). Stage classification (ACC/AHA Stage A–D and NYHA I–IV) is frequently asked.

4. Valvular heart disease. Aortic stenosis vs mitral regurgitation vs mitral stenosis vs aortic regurgitation. Murmur character + radiation + manoeuvres (squat, Valsalva, hand-grip) effect. Indications for surgical intervention.

5. Hypertension. WHO 2023 thresholds (130/80 vs 140/90), ACC/AHA 2017 staging, first-line drugs by comorbidity (ACE-I in diabetes/CKD, CCB in elderly, diuretic in African-Indian population), resistant hypertension workup.

★ Endocrinology (Topics 6–9)

6. Diabetes mellitus — T1 vs T2 + newer drugs. Pathophysiology differentiation, HbA1c targets (<7% for most, <8% in frail elderly), DKA precipitants in T1, SGLT2 inhibitors and GLP-1 receptor agonists (semaglutide, liraglutide) — both increasingly tested.

7. Diabetic ketoacidosis (DKA) vs hyperosmolar hyperglycaemic state (HHS). Anion gap, ketones, osmolality cut-offs. Management priorities: fluids first, then insulin infusion, then potassium replacement — never start insulin if K⁄sup>+⁄sup> <3.3 mEq/L. Asked nearly every year.

8. Thyroid function test interpretation. Subclinical vs overt hypo- and hyperthyroidism, sick-euthyroid pattern, central vs primary hypothyroidism (TSH-only screening fails here), Graves vs toxic nodular goitre vs subacute thyroiditis.

9. Adrenal disorders. Cushing’s syndrome workup (low-dose dex suppression first), Addison’s disease (hyperpigmentation + hyponatraemia + hyperkalaemia), pheochromocytoma triad (headache, palpitations, sweating) + diagnostic test order (plasma metanephrines first).

★ Infectious Diseases (Topics 10–14)

10. HIV. Window period, NACO ART guidelines (Tenofovir + Lamivudine + Dolutegravir is current first-line), opportunistic infection CD4 thresholds (PCP <200, MAC <50, CMV <50), prophylaxis cut-offs, PEP & PrEP regimens.

11. Tuberculosis. NTEP (replaced RNTCP) drug regimen for new vs previously treated, DOTS-Plus for MDR-TB, BPaL/M regimen for XDR, IGRA vs Mantoux interpretation. Very frequently asked.

12. Hepatitis B serology (NBEMS trap). HBsAg, anti-HBs, HBeAg, anti-HBe, anti-HBc IgM vs IgG, HBV DNA. The window period (HBsAg negative, anti-HBs not yet positive, anti-HBc IgM positive) is the single most commonly tested ID concept — and the easiest to confuse under pressure.

13. Hepatitis C. Genotyping, direct-acting antivirals (sofosbuvir + velpatasvir / glecaprevir + pibrentasvir), 12-week cure regimens, treatment success rates.

14. Malaria differentiation. Plasmodium falciparum vs vivax vs ovale vs malariae — peripheral smear features, complications (cerebral malaria, blackwater fever in falciparum), regional drug regimens (artemisinin combination therapy, chloroquine in vivax). Northeast India NVBDCP sub-policy uses AL+PQ for falciparum — flagged frequently.

★ Nephrology (Topics 15–17)

15. Chronic kidney disease (CKD) staging. KDIGO 2024 categories (G1–G5 by eGFR, A1–A3 by albuminuria), indications for renal replacement therapy, anaemia + bone-mineral disorder management.

16. Acute kidney injury (AKI). KDIGO criteria (creatinine rise vs urine output), pre-renal vs intrinsic vs post-renal differentiation, FENa/FEUrea interpretation, ATN vs AIN biopsy features.

17. Glomerulonephritis — nephrotic vs nephritic. Histology pattern recognition: minimal change, FSGS, membranous, post-streptococcal GN, IgA nephropathy, lupus nephritis (Class I–VI). Tested with case + biopsy image.

★ Respiratory (Topics 18–20)

18. Asthma (GINA 2025). Stepwise treatment, ICS-formoterol as preferred reliever (MART concept), severity classification, asthma exacerbation management.

19. COPD (GOLD 2025). ABE classification (replaced ABCD in 2023), spirometry interpretation (FEV1/FVC <0.7 post-bronchodilator), pharmacologic and non-pharmacologic management, indications for long-term oxygen therapy.

20. Community-acquired pneumonia (CAP). CURB-65 / PSI severity scoring, atypical vs typical pathogen, empirical regimens (amoxicillin in OPD, azithromycin + ceftriaxone in ward, with anti-pseudomonal cover in ICU).

★ Neurology (Topics 21–24)

21. Stroke — ischemic vs haemorrhagic. Thrombolysis criteria (within 4.5 hours, exclusion list memorised verbatim), mechanical thrombectomy window (up to 24 hours in select patients), Bamford / Oxford classification, secondary prevention regimens.

22. Seizures and AEDs. Focal vs generalised classification, status epilepticus management ladder (benzo → phenytoin/levetiracetam → valproate → phenobarb → ICU), drug-of-choice per seizure type (sodium valproate broad-spectrum, ethosuximide for absence, carbamazepine for focal).

23. Movement disorders. Parkinson disease (clinical diagnostic features, levodopa + carbidopa + COMT/MAO-B inhibitors), Wilson disease (Kayser-Fleischer ring, low ceruloplasmin, 24-hour urinary copper, penicillamine), Huntington (CAG repeat, autosomal dominant).

24. Demyelinating disorders. Multiple sclerosis (McDonald criteria, MRI “Dawson’s fingers,” first-line DMTs), Guillain-Barré syndrome (ascending paralysis, albuminocytologic dissociation in CSF, IVIG vs plasmapheresis).

★ Gastroenterology & Hepatology (Topics 25–26)

25. Cirrhosis & portal hypertension complications. Variceal bleeding management (octreotide, ceftriaxone prophylaxis, band ligation, TIPS), spontaneous bacterial peritonitis diagnosis (ascitic PMN >250/µL) and treatment, hepatic encephalopathy (lactulose + rifaximin), hepatorenal syndrome.

26. Inflammatory bowel disease — UC vs Crohn’s. Distribution (continuous from rectum in UC; skip lesions terminal ileum in Crohn’s), histology (crypt abscesses in UC; non-caseating granulomas + transmural in Crohn’s), extra-intestinal manifestations, treatment escalation (5-ASA → steroids → immunomodulators → biologics).

★ Rheumatology (Topics 27–28)

27. Rheumatic fever & rheumatic heart disease. Revised Jones criteria (high-risk vs low-risk populations), Aschoff body pathology, secondary prophylaxis duration (penicillin G benzathine for 5 years / till age 21 / till age 40 / lifelong by category).

28. SLE diagnostic criteria. 2019 EULAR/ACR criteria with weighted scoring, ANA + dsDNA + anti-Smith pattern, lupus nephritis class I–VI, classic mucocutaneous + serosal + haematologic manifestations.

★ Hematology & Critical Care (Topics 29–30)

29. Anaemia workup. MCV-based approach: microcytic (iron deficiency vs thalassaemia vs anaemia of chronic disease), normocytic (acute blood loss, haemolysis, early iron deficiency), macrocytic (B12 / folate deficiency, alcohol, hypothyroidism). Peripheral smear features — very frequent image-based question.

30. Sepsis and septic shock. Sepsis-3 criteria, qSOFA bedside screen (RR ≥22, AMS, SBP ≤100), Surviving Sepsis Campaign 2021 hour-1 bundle (lactate, blood cultures, broad-spectrum antibiotics, 30 mL/kg crystalloid, vasopressors for MAP <65). Increasingly tested with ICU vignettes.

Common NEET-PG Medicine Traps to Avoid

• Hepatitis B window period — the textbook trap. Remember: anti-HBc IgM is the ONLY positive marker in the window.
• “All EXCEPT” questions — appear 8–10 times per paper. Read the negation twice before answering.
• Drug-interaction questions. Rifampicin reduces effectiveness of warfarin, OCPs, cyclosporine. Frequently asked as a clinical vignette (transplant patient on ATT → rejection).
• Subclinical vs overt thyroid disease — the “treat or not treat” question depends on TSH cut-off (>10 mIU/L) and symptoms.
• Region-specific malaria regimens — Northeast India uses AL+PQ for falciparum, not AS+SP. Stem location matters.
• SGLT2 inhibitors have moved into first line for HFrEF, T2DM with CKD, and CKD irrespective of diabetes — older textbooks still place them as second-line. Trust the recent guideline updates.

A 4-Week Medicine Mastery Plan

If you have 4 weeks dedicated to Medicine revision, here’s the breakdown that hits all 30 topics.

End each week with a mini-test of 40 mixed Medicine MCQs in 26 minutes (NEET-PG section pace). Identify your weakest topic from each week’s mini-test and revisit it on the weekend.

Recommended Resources for Medicine

• Primary text: Harrison’s Principles of Internal Medicine — selective chapters only. Don’t attempt full-book reads in the last 6 months.
• Indian PG review: One standard review book (Mudit Khanna / Across PG / Marrow notes) for compressed first reading.
• Guidelines: Recent (within 2 years) NICE, GOLD, GINA, KDIGO, NACO documents for any guideline-anchored topic.
• Question bank: The Kinase QBank tags every Medicine question by sub-specialty and PYQ year — ideal for the weekly mini-tests above.

Frequently Asked Questions

How many marks is Medicine in NEET-PG 2026?

Approximately 21 questions worth 84 marks (each question is +4/−1). That’s about 10.5% of the 800-mark paper — the single highest weight of any subject, narrowly above Surgery (which includes Orthopedics).

Which Medicine textbook is best for NEET-PG 2026?

Harrison’s for in-depth concept clarity (selective chapters), plus one Indian PG review for compressed revision. Don’t rotate between three different review books — pick one and finish it. The biggest rank-killer is starting a new text in month 11.

Should I cover all of Medicine or focus on high-yield topics?

Cover the high-yield 30 to mastery and skim the rest. The 80/20 rule applies hard here — the 30 topics above account for an estimated 80% of NEET-PG Medicine marks. Don’t skip rare topics entirely; aim to recognise them at least.

How long should I take to finish Medicine for NEET-PG 2026?

First reading: 6–8 weeks (during your foundation phase). Subject-wise QBank pass: 3 weeks. Final revision: 4 weeks (the plan above). Total dedicated Medicine time across a 12-month prep: ~13–15 weeks of meaningful contact.

Do NEET-PG PYQs cover Medicine adequately?

Roughly 30% of Medicine concepts recur from previous years (rarely verbatim). PYQs are necessary but not sufficient — complement them with a structured QBank and at least 5 Grand Tests in Medicine-heavy mode to catch the new pattern questions.

Closing Note

Medicine looks intimidating because of its volume. But once you reframe it as 30 high-yield concepts with predictable testing patterns, it becomes the most leveraged subject in your prep — one mastered Medicine topic earns marks in Medicine, Surgery, Pharmacology, and OBG simultaneously. Start with the cardiology block, finish with sepsis, and trust the cross-subject compounding.

References:

• PrepLadder. High-Yield Topics for NEET-PG 2026. prepladder.com
• Physics Wallah Live. NEET-PG High-Yield Topics You Should Focus On in 2026. pw.live